History of clinical trials for the treatment of tuberculosis in China. Part 2: the advent and expansion of randomised controlled trials

Fu Y Li M Chen Y. The impact of drug-resistant bacteria on surgical treatment of tuberculosis. Chin J Antitubercul 1963; 5: 299–302. [傅堯箕,李敏学,陈玉平 (1963). 耐药菌对肺结核切除疗法的影响. 中国防痨杂志 5: 299–302.]

Li S Xiao C. Factors influencing and effectiveness of chemotherapy in non-hospitalized pulmonary tuberculosis patients. Chin J Antitubercul 1963; 2: 76–83. [李树森,肖成志 (1963). 不住院肺结核病人化学疗法的影响因素及效果分析. 中国防痨杂志 2: 76–83.]

Xu X Tan Q Cheng N Zhu C Guan S Zhang X , et al. Discussion on chemotherapy treatment for 1,000 non-hospitalized tuberculosis cases. Chin J Antitubercul 1963; 2: 84–87. [许学受,谈清霖,程南,等 (1963). 1000例肺结核病例不住院化学治疗的探讨. 中国防痨杂志 2: 84–87.]

Xiao C. Comments on the article ‘Discussion on chemotherapy treatment for 1,000 non-hospitalized tuberculosis cases’. Chin J Antitubercul 1965; 1: 54–55. [肖成志 (1965). 对《1,000例肺结核病例不住院化学治疗的探讨》一文的意见. 中国防痨杂志 1: 54–55.]

Wang Z. Discussion on the article ‘Discussion on chemotherapy treatment for 1,000 non-hospitalized tuberculosis cases’. Chin J Antitubercul 1965; 1: 53. [王致春 (1965). 对《1,000例肺结核病例不住院化学治疗的探讨》一文的探讨. 中国防痨杂志 1: 53.]

Wang S Chu Y Zhang Z Jin Z Jiang Y Yang D . Comparison of the efficacy of different treatment regimens for initial therapy of tuberculosis. Chin J Antituberculs 1963; 4: 227–233. [汪士,諸云程,張振朝,等 (1963). 肺結核病初次治疗不同用药方法的疗效比較. 中国防痨杂志 4: 227–233.]

Medical Research Council. Various combinations of isoniazid with streptomycin or with PAS in the treatment of pulmonary tuberculosis. Br Med J 1955; 1: 435–445.

Phillips S. Comparison of isoniazid alone with isoniazid – PAS in the original chemotherapy of noncavitary pulmonary tuberculosis. Results from the Veterans Administration-Armed Forces co-operative study on the chemotherapy of tuberculosis. Am Rev Respir Dis 1959; 80: 641–647.

East African Hospitals/British Medical Research Council. Comparative trial of isoniazid alone in low and high dosage and isoniazid plus PAS in the treatment of acute pulmonary tuberculosis in East Africans. Tubercle 1960; 41: 83–102.

Tuberculosis Chemotherapy Centre, Madras. A concurrent comparison of isoniazid plus PAS with three regimens of isoniazid alone in the domiciliary treatment of pulmonary tuberculosis in South India. Bull World Health Organization 1960; 23: 535–585.

Zhang J. Dosage and administration of PAS in the treatment of tuberculosis. Chin J Antitubercul 1966; 1: 31–33. [张錦垣 (1966). 对氨基水楊酸治疗肺結核的用量和用法. 中国防痨杂志 1: 31–33.]

Shen Z. Efficacy analysis of isoniazid ‘single oral dose method’ in outpatient initial treatment of 145 cases of tuberculosis. Chin J Antitubercul 3: 141–143. [沈冶六 (1965). 異菸肼‘一次口服法’門初治肺結核145例疗效分析. 中国防痨杂志 3: 141–143.]

Tong J Wang C Xu F Chen M . Comparison of daily vs. intermittent streptomycin administration in the treatment of initial cases of tuberculosis. Chin J Antitubercul 1966; 1: 29–30. [童驥,王承美,徐富良,等 (1966). 鏈霉素每日应用和間歇应用治疗肺結核初治病例的疗效比較. 中国防痨杂志 1: 29–30.]

Medical Research Council. Isoniazid in combination with streptomycin or with PAS in the treatment of pulmonary tuberculosis. Br Med J 1953; 2: 1005–1014.

Yu X, Chen Y and Podolsky S. 2025. The History of Controlled Clinical Trials in China. JLL Bulletin: Commentaries on the history of treatment evaluation. See www.jameslindlibrary.org/articles/the-history-ofcontrolled-clinical-trials-in-china/ (last checked 7 May 2025).

Huang D. Celebrating the re-launch of the ‘Chinese Journal of Antituberculosis’. Chin J Antitubercul 1979; 00: 1–2. [黄鼎臣 (1979). 祝‘中国防痨通讯’复刊. 中国防痨通讯 00: 1–2.]

Li L Tang S. Remembering the past and looking to the future: an essay on the 70th anniversary of the Chinese Journal of Tuberculosis and Respiratory Diseases. Chin J Tubercul Respir Dis 2024; 47: 1–2. [李亮,唐神结 (2024). 谨记历史 着眼未来——《中华结核和呼吸杂志》创刊70周年随笔. 中华结核和呼吸杂志 47: 1–2.]

East African/British Medical Research Councils. Controlled clinical trial of short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Lancet 1972; 1: 1079–1085.

Hong Kong Tuberculosis Treatment Services/British Medical Research Council. Controlled trial of 6- and 9-month regimens of daily and intermittent streptomycin plus isoniazid plus pyrazinamide for pulmonary tuberculosis in Hong Kong. Tubercle 1975; 56: 81–96.

Hong Kong Chest Service/British Medical Research Council. Controlled trial of 6-month and 9-month regimens of daily and intermittent streptomycin plus isoniazid plus pyrazinamide for pulmonary tuberculosis in Hong Kong. The results up to 30 months. Am Rev Respir Dis 1977; 115: 727–735.

Hong Kong Chest Service/British Medical Research Council. Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. Am Rev Respir Dis 1978; 118: 219–228.

Hong Kong Chest Service/British Medical Research Council. Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis: the results up to 24 months. Tubercle 1979; 60: 201–210.

Hong Kong Chest Service/British Medical Research Council. Controlled trial of four thrice-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis. Lancet 1981; 1: 171–174.

Hong Kong Chest Service/British Medical Research Council. Controlled trial of 4 three-times weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis. Second report: the results up to 24 months. Tubercle 1982; 63: 89–98.

Hong Kong Chest Service/British Medical Research Council. Five-year follow-up of a controlled trial of five 6-month regimens of chemotherapy for pulmonary tuberculosis. Am Rev Respir Dis 1987; 136: 1339–1342.

Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council. A controlled clinical comparison of 6 and 8 months of antituberculosis chemotherapy in the treatment of patients with silicotuberculosis in Hong Kong. Am Rev Respir Dis 1991; 143: 262–267.

Hong Kong Chest Service/British Medical Research Council. Controlled trial of 2, 4 and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin and pyrazinamide. Am Rev Respir Dis 1991; 143: 700–706.

National Coordinating Group of Investigations on Short-course Chemotherapy. Study on short-course chemotherapy for tuberculosis. Chin J Tubercul Respir Dis 1982; 5: 78–81. [全国肺结核短化协作组 (1982). 肺结核短程化疗的研究. 中华结核和呼吸杂志 5: 78–81.]

National Coordinating Group of Investigations on Short-course Chemotherapy. Preliminary Report on the second batch of short-course chemotherapy research for tuberculosis. Chin J Tubercul Respir Dis 1984; 7: 198–202. [全国肺结核短化协作组 (1984). 第二批肺结核短程化疗研究初报. 中华结核和呼吸系疾病杂志 7: 198–202.]

Kan G. The role of chemotherapy in controlling tuberculosis epidemics. Chin J Antitubercul 1980; 1: 1–4. [阚冠卿 (1980). 化学疗法在控制结核病流行中的作用. 中国防痨通讯 1: 1–4.]

Toman K. Tuberculosis Case-Finding and Chemotherapy. Geneva: WHO, 1979.

Hong Kong Tuberculosis and Chest Service. 2024. Historical summary of TB and services in Hong Kong. See www.info.gov.hk/tb_chest/en/contents/c13.htm (last checked 7 May 2025).

Kan G. Tuberculosis control efforts in Hong Kong. Chin J Antitubercul 1986; 2: 1–3. [阚冠卿 (1986). 香港的防痨工作. 中国防痨通讯 2: 1–3.]

Chen Z Guo Z Jin S. The role of scientific research in tuberculosis chemotherapy efforts in Hong Kong. Chin J Antitubercul 1991; 3: 100–102. [陈兆麟,郭仲珂,金沙江 (1991). 科学研究在香港结核病化疗工作中的作用. 中国防痨杂志 3: 100–102.]

Lee S. Anti-tuberculosis work in Hong Kong, past and future. Chin J Antitubercul 1996; 2: 49–52. [李绍鸿 (1996). 香港防痨工作的过去和展望. 中国防痨杂志 2: 49–52.]

Jinzhou Zijing Mountain Tuberculosis Hospital. The efficacy of traditional Chinese medicine in the treatment of tuberculosis. Liaoning J Trad Chin Med 1958; 1: 20–24. [锦州市紫荆山结核医院 (1958). 中医药对肺结核的疗效. 辽宁中医杂志 1: 20–24.]

Zhang B. Research on traditional Chinese medicine and herbal medicine in tuberculosis over the past ten years. Chin J Antitubercul 1959; 5: 3–9. [张本 (1959). 十年来有关中医中药在结核病方面的研究. 中国防痨 5: 3–9.]

Fifty-first Hospital of the Chinese People’s Liberation Army. Efficacy observation of Bai Ji Alone in the treatment of 60 cases of tuberculosis. J New Med 1975; 12: 564–565. [人民解放军第51医院 (1975). 单用白芨治疗肺结核60例疗效观察. 新医学 12: 564–565.]

Zhang Z He L Hou Y Zhou G Zheng S Cao T , et al. Clinical observation of 60 cases of tuberculosis treated with tuberculins and chemotherapy. Heilongjiang J Tradition Chin Med 1992; 4: 24–25. [张政,何立生,候玉梅,等 (1992). 结核散并用化学疗法治疗肺结核60例临床观察. 黑龙江中医药 4: 24–25.]

Wei B Guo Q Xi Y Yang X Yang G Zhang Y . Efficacy observation of anti-tuberculosis Yifei decoction in the treatment of 60 cases of tuberculosis. Hebei J Tradition Chin Med 1995; 6: 9–10. [魏兵军,郭庆儒,席永昌,等 (1995). 抗痨益肺冲剂治疗肺结核60例疗效观察. 河北中医 6: 9–10.]

National Medical Products Administration. Announcement by the National Medical Products Administration on the Simplified Registration and Approval Management Regulations for Classic Ancient Formulas of Traditional Chinese Medicine Compound Preparations (2018 No. 27). 2018.6.1. 2018. See www.nmpa.gov.cn/zhuanti/ypqxgg/ggzhcfg/20180601163901361.html (last checked 7 May 2025). [国家药品监督管理局关于发布古代经典名方中药复方制剂简化注册审批管理规定的公告（2018年第27号）(2018). 2018.6.1.]

Luo H Chen H Liu C Zhang S Vong CT Tan D , et al. The key issues and development strategy of Chinese Classical Formulas pharmaceutical preparations. Chin Med 2021; 16: 1–14.

Traditional Chinese medicine needs proper scrutiny. Nature 2017; 551: 541.

Guo Y Kang Z Fu L Zhang W Wang B Hu P , et al. Meta-analysis of clinical evaluation of traditional Chinese medicine in the treatment of tuberculosis. China Trop Med 22: 434–439. [郭毅佳,康子卿,付雷,等 (2022). 中药治疗结核病临床评价的Meta分析. 中国热带医学 22: 434–439.]

Feng W Liu Y He F Liu C Ye Z Fu Z , et al. A multicenter middle-term clinical effect observation of Yifei Tongluo prescription combined with chemotherapy on the treatment of multi-drug resistant tuberculosis. J Hunan Univ Chin Med 2014; 34: 46–50. [封文军,刘艳科,何芳,等 (2014). 益肺通络方联合西药化疗对耐多药肺结核的多中心临床中期疗效观察. 湖南中医药大学学报 34: 46–50.]

Xi X Li M Wang X Wu Z Shang H . Efficacy and safety of Qijialifei capsule in adjuvant chemotherapy for retreatment pulmonary tuberculosis. Chin J Antitubercul 2014; 11: 948–952. [席秀娥,李明瑛,王霞,等 (2014). 芪甲利肺胶囊辅助治疗复治肺结核的疗效及安全性观察. 中国防痨杂志 11: 948–952.]

Ge Q Dong T. The first academic symposium held by the tuberculosis committee of the Beijing Municipal Science and Technology Commission. Chin J Antitubercul 1959; 3: 43–44. [歌青,董天光 (1959). 北京市科学技术委员会结核病科委员会举办第一次学术报告会. 中国防痨 3: 43–44.]